・業績
 ・受賞・表彰
 ・資格・認定
 ・認定施設
 業績 [ 2019年 ] 過去の業績はこちらから

原著論文(英文)
1. Ito-Takeichi S, Niwa T, Fujibayashi A, Suzuki K, Ohta H, Niwa A, Tsuchiya M, Yamamoto M, Hatakeyama D, Suzuki A, Baba H, Murakami N, Itoh Y. The impact of implementing an antifungal stewardship with monitoring of 1-3, β-D-glucan values on antifungal consumption and clinical outcomes. J Clin Pharm Ther. (in press)
2. Niwa T, Yonetamari J, Hayama N, Fujibayashi A, Ito-Takeichi S, Suzuki K, Ohta H, Niwa A, Tsuchiya M, Yamamoto M, Hatakeyama D, Hayashi H, Obara M, Sugiyama T, Baba H, Suzuki A, Murakami N. Clinical impact of matrix-assisted laser desorption ionization-time of flight mass spectrometry combined with antimicrobial stewardship interventions in patients with bloodstream infections in a Japanese tertiary hospital. Int J Clin Pract. (in press)
3. Horikawa Y, Suzuki A, Enya M, Hashimoto K, Nishida S, Kobayashi R, Ohashi T, Yamazaki F, Totani R, Kobayashi H, Yamamoto M, Itoh Y, Takeda J. Periodontal disease may be associated with the occurrence of diabetic retinopathy: A subgroup analysis of the survey of the Diabetes Coordination Notebook in Gifu. Exp Clin Endocrinol Diabetes. (in press)
4. Matsuhashi N, Takahashi T, Fujii H, Iihara H, Suetsugu T, Iwata Y, Tajima JY, Imai T, Mori R, Tanahashi T, Matsui S, Imai H, Tanaka Y, Yamaguchi K and Yoshida K. Preventive Effect and Safety of Pregabalin for FOLFOX-Related Peripheral Neurotoxicity in Patients with Advanced and Recurrent Colorectal Cancer: The Perpetual Study Estimated by United Sections in Gifu for Colorectal Cancer (Perseus CRC-01 Study). Clinics of Oncology. 1: 1-6, 2019

著書
1. 藤井宏典、飯原大稔.特集・Evidence Update 2019最新の薬物治療のエビデンスを付加的に利用する「エキスパートが注目する最新エビデンスをアップデート!:大腸癌治療薬」.薬局70:p167-172.南山堂、2019